House Energy & Commerce Chair Frank Pallone (D-NJ) said he has been working with FDA, GOP lawmakers and industry for several weeks to modify his bill beefing up FDA’s power to regulate cosmetics, and he revealed Wednesday (Dec. 4) that he is changing the ingredient review and user fee language and is open to adding some type of preemption clause. Pallone made the remarks at an E&C health subcommittee hearing that featured both his bill and a similar one from...